RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.
A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
- Chemical Identification
- Environmental Hazards
- First Aid/Medical Treatment
- Handling/Storage/Shipping/Waste Management
- Personal Protection
- Physical Hazards/Corrective Response Actions
- Physical/Chemical Properties
- Report Abstracts and Studies
- Reproductive Risk
- Toxicology/Health Hazards/Exposure
|Example of Acute Exposure data from MEDITEXT.|
RightAnswer Proprietary Data Sources:
Other Government Links Searched via RegsKnowledge:
State Environmental Regulations
Example Content from MEDITEXT for 92623-85-3:
Please note: this is an extract of information from a larger document. Full document and details are available by subscription.
ACUTE EXPOSURE INFORMATION
- USES: Selective serotonin and norepinephrine reuptake inhibitor (SSNRI) used in the management of fibromyalgia.
- PHARMACOLOGY: Inhibits neuronal norepinephrine and serotonin reuptake; thus potentiating the serotonergic and noradrenergic activity in the CNS.
- TOXICOLOGY: Primarily sympathomimetic activity, potential for serotonin syndrome.
- EPIDEMIOLOGY: Several deliberate poisonings have been reported in postmarketing experience. Fatalities are rare.
- WITH THERAPEUTIC USE
- COMMON: Headache, nausea and vomiting, constipation, hypertension, tachycardia and palpitations. Elevated liver enzymes have been reported.
- WITH POISONING/EXPOSURE
- MILD TO MODERATE TOXICITY: Somnolence, nausea and vomiting are common. Tachycardia and hypertension have been reported.
- SEVERE TOXICITY: Milnacipran may cause seizures and serotonin syndrome. Acute stress cardiomyopathy developed in a woman after ingesting 3000 mg of milnacipran.
© 2011-2020 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.